(Q35040802)

English

Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

pharmacotherapy

0 references

author name string

Farvolden P

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Kennedy SH

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Lam RW

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

65-86

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Prevalence and 12-month outcome of threshold and subthreshold mental disorders in primary care.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Outcome for adjustment disorder with depressed mood: comparison with other mood disorders

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

An international study of the relation between somatic symptoms and depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The interaction of drug- and psychotherapy in the long-term treatment of depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

St John's wort for depression: a systematic review

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

A novel augmentation strategy for treating resistant major depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Discontinuing antidepressant treatment in major depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Comparative effects of seven antidepressant regimes on appetite, weight and carbohydrate preference

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Effects of SSRIs on sexual function: a critical review

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Sexual functioning in depressed outpatients taking mirtazapine

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Selective alteration of personality and social behavior by serotonergic intervention

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The neurobiology of suicide

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Role of 5-HT in stress, anxiety, and depression.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Co-localization of 5-HT1B- and 5-HT1D receptor mRNA in serotonergic cell bodies in guinea pig dorsal raphé nucleus: a double labeling in situ hybridization histochemistry study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Evidence that 5-hydroxytryptamine release in rat dorsal raphé nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Localization of serotonin(5A) receptors in discrete regions of the circadian timing system in the Syrian hamster

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Therapeutic potential of serotonin antagonists in depressive disorders

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

5HT7 receptors in the rodent suprachiasmatic nucleus

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Role of norepinephrine in the pathophysiology and treatment of mood disorders

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Monoamine receptors in the prefrontal cortex of Tupaia belangeri during chronic psychosocial stress.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Effect of isolation-rearing on noradrenaline release in rat hypothalamus and hippocampus in vitro.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Chronic variable stress induces supersensitivity of central alpha2-adrenoceptors which modulate the jaw-opening reflex in the rat.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

A predictive reinforcement model of dopamine neurons for learning approach behavior.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Signaling: cellular insights into the pathophysiology of bipolar disorder

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The cellular neurobiology of depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Behavioral and neuroendocrine responses in shy children.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Antiglucocorticoid drugs in the treatment of depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Neuroimaging studies of mood disorders

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Glial reduction in the subgenual prefrontal cortex in mood disorders

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Mind glue: implications of glial cell biology for psychiatry

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Toward a neuroanatomy of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Stress and hippocampal plasticity

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Hippocampal remodeling and damage by corticosteroids: implications for mood disorders.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Psychosomatic aspects of Cushing's disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

CREB couples neurotrophin signals to survival messages

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The Bcl-2 protein family: arbiters of cell survival

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Neuronal plasticity and survival in mood disorders.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Regulation of hippocampal neurogenesis in adulthood.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Neurogenesis in the neocortex of adult primates

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Bcl-2 expression in thalamus, brainstem, cerebellum and visual cortex of adult primate.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Adult brain neurogenesis and psychiatry: a novel theory of depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Inositol addition does not improve depression in SSRI treatment failures.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The gabaergic hypothesis of depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

DARPP-32 mediates serotonergic neurotransmission in the forebrain

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac).

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The tachykinin NK1 receptor in the brain: pharmacology and putative functions

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Neuropeptide Y, neurokinin A and neurotensin in brain regions of Fawn Hooded "depressed", Wistar, and Sprague Dawley rats. Effects of electroconvulsive stimuli

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Novel approaches to targeting neuropeptide systems

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A-independent transacylase.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Omega-3 fatty acids in major depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Imidazoline receptors: possible involvement in the pathophysiology and treatment of depression.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Brain circuits in panic disorder

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other an

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Differential effect of serotonin 5-HT(1A) receptor antagonists on the secretion of corticotropin and prolactin

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Recent advances in 5-HT1B/1D receptor antagonists and agonists and their potential therapeutic applications

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Further characterisation of potential antidepressant action of flibanserin

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Tianeptine: a review of its use in depressive disorders

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Effect of two antidepressant drugs on REM sleep and EMG activity during sleep.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Enhancement of memory consolidation in chicks by beta(3)-adrenoceptor agonists

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Central 5-HT2A and D2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy men.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Bi

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Rapid reversal of psychotic depression using mifepristone

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The brain mineralocorticoid receptor: greedy for ligand, mysterious in function.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

New anti-epileptic drugs

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Glutamate receptors in the mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Use of topiramate, a new anti-epileptic as a mood stabilizer.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Permeability of the blood-brain barrier to neurotrophins.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Designing small-molecule switches for protein-protein interactions

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Effects of alpha 4/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Functional genomics and depression research. Beyond the monoamine hypothesis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

SB-236057-A: a selective 5-HT1B receptor inverse agonist

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Cross-national epidemiology of major depression and bipolar disorder

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

Localization of 5-ht5A receptor-like immunoreactivity in the rat brain

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.1.65

21 January 2018

A new neuritogenetic compound BU-4514N produced by Microtetraspora sp

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.46.875

A novel substance with TGF-beta like activity, diheteropeptin, produced by a fungus, Diheterospora sp

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.50.1058

Identifiers

10.1517/13543784.12.1.65

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35040802&oldid=2127357002"